Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
Amgen entered China in 2012 with a mission to serve patients. We are dedicated to introducing and developing innovative therapies that address the needs of Chinese patients. Our efforts focus on four key therapeutic areas: general medicine, rare disease, oncology and inflammation. To date, we have introduced eight innovative medicines into the Chinese market.
For more information, please visit our global website, or contact professionals at Amgen China.
websites and leave Amgen.cn?
Amgen China takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the China regulatory environment.